PubMed:32712222
Annnotations
LitCovid-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-8 | UBERON:0004877 | denotes | Visceral |
| T2 | 94-102 | SP_7 | denotes | COVID-19 |
| T3 | 181-189 | SP_7 | denotes | COVID-19 |
| T4 | 461-469 | SP_7 | denotes | COVID-19 |
| T5 | 482-491 | UBERON:0007808 | denotes | abdominal |
| T6 | 492-495 | UBERON:0001013 | denotes | fat |
| T7 | 570-575 | UBERON:0001443 | denotes | chest |
| T8 | 756-766 | SP_7 | denotes | SARS-Cov-2 |
| T9 | 783-788 | UBERON:0001443 | denotes | chest |
| T10 | 939-947 | UBERON:0004877 | denotes | Visceral |
| T11 | 953-956 | UBERON:0004044 | denotes | VAT |
| T12 | 1136-1148 | UBERON:0005169 | denotes | interstitial |
| T13 | 1185-1189 | UBERON:0002048 | denotes | Lung |
| T14 | 1240-1251 | CL:0000542 | denotes | lymphocytes |
| T15 | 1283-1292 | UBERON:0007808 | denotes | abdominal |
| T16 | 1293-1296 | UBERON:0001013 | denotes | fat |
| T17 | 1308-1311 | UBERON:0001348 | denotes | VAT |
| T18 | 1686-1694 | SP_7 | denotes | COVID-19 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 422-426 | Body_part | denotes | body | http://purl.org/sig/ont/fma/fma256135 |
| T2 | 511-515 | Body_part | denotes | body | http://purl.org/sig/ont/fma/fma256135 |
| T3 | 570-575 | Body_part | denotes | chest | http://purl.org/sig/ont/fma/fma9576 |
| T4 | 783-788 | Body_part | denotes | chest | http://purl.org/sig/ont/fma/fma9576 |
| T5 | 1185-1189 | Body_part | denotes | Lung | http://purl.org/sig/ont/fma/fma7195 |
| T6 | 1240-1251 | Body_part | denotes | lymphocytes | http://purl.org/sig/ont/fma/fma62863 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 0-12 | Body_part | denotes | Visceral fat | http://purl.obolibrary.org/obo/UBERON_0035818 |
| T2 | 570-575 | Body_part | denotes | chest | http://purl.obolibrary.org/obo/UBERON_0001443 |
| T3 | 783-788 | Body_part | denotes | chest | http://purl.obolibrary.org/obo/UBERON_0001443 |
| T4 | 939-951 | Body_part | denotes | Visceral fat | http://purl.obolibrary.org/obo/UBERON_0035818 |
| T5 | 953-956 | Body_part | denotes | VAT | http://purl.obolibrary.org/obo/UBERON_0035818 |
| T6 | 1185-1189 | Body_part | denotes | Lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
| T7 | 1308-1311 | Body_part | denotes | VAT | http://purl.obolibrary.org/obo/UBERON_0035818 |
| T8 | 1445-1448 | Body_part | denotes | VAT | http://purl.obolibrary.org/obo/UBERON_0035818 |
| T9 | 1626-1629 | Body_part | denotes | VAT | http://purl.obolibrary.org/obo/UBERON_0035818 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 94-102 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T2 | 116-123 | Disease | denotes | Obesity | http://purl.obolibrary.org/obo/MONDO_0011122 |
| T3 | 181-189 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T4 | 461-469 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T5 | 756-760 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T6 | 1062-1074 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
| T7 | 1149-1158 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
| T8 | 1206-1209 | Disease | denotes | LSS | http://purl.obolibrary.org/obo/MONDO_0007615 |
| T9 | 1272-1275 | Disease | denotes | LSS | http://purl.obolibrary.org/obo/MONDO_0007615 |
| T10 | 1437-1440 | Disease | denotes | LSS | http://purl.obolibrary.org/obo/MONDO_0007615 |
| T11 | 1686-1694 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 9-12 | http://purl.obolibrary.org/obo/UBERON_0001013 | denotes | fat |
| T2 | 151-152 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T3 | 386-391 | http://purl.obolibrary.org/obo/CLO_0009985 | denotes | focus |
| T4 | 427-430 | http://purl.obolibrary.org/obo/UBERON_0001013 | denotes | fat |
| T5 | 432-435 | http://purl.obolibrary.org/obo/PR_000001343 | denotes | Aim |
| T6 | 492-495 | http://purl.obolibrary.org/obo/UBERON_0001013 | denotes | fat |
| T7 | 499-500 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T8 | 568-569 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T9 | 570-575 | http://www.ebi.ac.uk/efo/EFO_0000965 | denotes | chest |
| T10 | 736-742 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
| T11 | 781-782 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T12 | 783-788 | http://www.ebi.ac.uk/efo/EFO_0000965 | denotes | chest |
| T13 | 908-912 | http://purl.obolibrary.org/obo/UBERON_0003101 | denotes | male |
| T14 | 908-912 | http://www.ebi.ac.uk/efo/EFO_0000970 | denotes | male |
| T15 | 948-951 | http://purl.obolibrary.org/obo/UBERON_0001013 | denotes | fat |
| T16 | 1183-1184 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T17 | 1185-1189 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | Lung |
| T18 | 1185-1189 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | Lung |
| T19 | 1293-1296 | http://purl.obolibrary.org/obo/UBERON_0001013 | denotes | fat |
| T20 | 1331-1332 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T21 | 1401-1402 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T22 | 1633-1634 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 908-912 | Chemical | denotes | male | http://purl.obolibrary.org/obo/CHEBI_30780 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1062-1074 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2 | 80-88 | Species | denotes | Patients | Tax:9606 |
| 3 | 94-102 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 17 | 181-189 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 18 | 461-469 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 19 | 548-556 | Species | denotes | patients | Tax:9606 |
| 20 | 594-602 | Species | denotes | Patients | Tax:9606 |
| 21 | 756-766 | Species | denotes | SARS-Cov-2 | Tax:2697049 |
| 22 | 878-886 | Species | denotes | patients | Tax:9606 |
| 23 | 986-994 | Species | denotes | patients | Tax:9606 |
| 24 | 1062-1074 | Disease | denotes | inflammation | MESH:D007249 |
| 25 | 1083-1094 | Gene | denotes | CRP and LDH | Gene:1401 |
| 26 | 1149-1158 | Disease | denotes | pneumonia | MESH:D011014 |
| 27 | 1253-1256 | Gene | denotes | CRP | Gene:1401 |
| 28 | 1672-1680 | Species | denotes | patients | Tax:9606 |
| 29 | 1686-1694 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 116-123 | Phenotype | denotes | Obesity | http://purl.obolibrary.org/obo/HP_0001513 |
| T2 | 1149-1158 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-103 | Sentence | denotes | Visceral fat shows the strongest association with the need of intensive Care in Patients with COVID-19. |
| T2 | 104-115 | Sentence | denotes | BACKGROUND: |
| T3 | 116-227 | Sentence | denotes | Obesity was recently identified as a major risk factor for worse COVID-19 severity, especially among the young. |
| T4 | 228-359 | Sentence | denotes | The reason why its impact seems to be less pronounced in the elderly may be due to the concomitant presence of other comorbidities. |
| T5 | 360-431 | Sentence | denotes | However, all reports only focus on BMI, an indirect marker of body fat. |
| T6 | 432-584 | Sentence | denotes | Aim To explore the impact on COVID-19 severity of abdominal fat as a marker of body composition easily collected in patients undergoing a chest CT scan. |
| T7 | 585-593 | Sentence | denotes | METHODS: |
| T8 | 594-811 | Sentence | denotes | Patients included in this retrospective study were consecutively enrolled among those admitted to an Emergency Department in Rome, Italy, who tested positive for SARS-Cov-2 and underwent a chest CT scan in March 2020. |
| T9 | 812-864 | Sentence | denotes | Data were extracted from electronic medical records. |
| T10 | 865-873 | Sentence | denotes | RESULTS: |
| T11 | 874-938 | Sentence | denotes | 150 patients were included (64.7% male, mean age 64 ± 16 years). |
| T12 | 939-1223 | Sentence | denotes | Visceral fat (VAT) was significantly higher in patients requiring intensive care (p = .032), together with age (p = .009), inflammation markers CRP and LDH (p < .0001, p = .003, respectively), and interstitial pneumonia severity as assessed by a Lung Severity Score (LSS) (p < .0001). |
| T13 | 1224-1400 | Sentence | denotes | Increasing age, lymphocytes, CRP, LDH, D-Dimer, LSS, total abdominal fat as well as VAT were found to have a significant univariate association with the need of intensive care. |
| T14 | 1401-1515 | Sentence | denotes | A multivariate analysis showed that LSS and VAT were independently associated with the need of intensive care (OR: |
| T15 | 1516-1529 | Sentence | denotes | 1.262; 95%CI: |
| T16 | 1530-1560 | Sentence | denotes | 1.0171-1.488; p = .005 and OR: |
| T17 | 1561-1574 | Sentence | denotes | 2.474; 95%CI: |
| T18 | 1575-1612 | Sentence | denotes | 1.017-6.019; p = .046, respectively). |
| T19 | 1613-1695 | Sentence | denotes | CONCLUSIONS: VAT is a marker of worse clinical outcomes in patients with COVID-19. |
| T20 | 1696-1852 | Sentence | denotes | Given the exploratory nature of our study, further investigation is needed to confirm our findings and elucidate the mechanisms underlying such association. |
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-103 | Sentence | denotes | Visceral fat shows the strongest association with the need of intensive Care in Patients with COVID-19. |
| T2 | 104-115 | Sentence | denotes | BACKGROUND: |
| T3 | 116-227 | Sentence | denotes | Obesity was recently identified as a major risk factor for worse COVID-19 severity, especially among the young. |
| T4 | 228-359 | Sentence | denotes | The reason why its impact seems to be less pronounced in the elderly may be due to the concomitant presence of other comorbidities. |
| T5 | 360-431 | Sentence | denotes | However, all reports only focus on BMI, an indirect marker of body fat. |
| T6 | 432-584 | Sentence | denotes | Aim To explore the impact on COVID-19 severity of abdominal fat as a marker of body composition easily collected in patients undergoing a chest CT scan. |
| T7 | 585-593 | Sentence | denotes | METHODS: |
| T8 | 594-811 | Sentence | denotes | Patients included in this retrospective study were consecutively enrolled among those admitted to an Emergency Department in Rome, Italy, who tested positive for SARS-Cov-2 and underwent a chest CT scan in March 2020. |
| T9 | 812-864 | Sentence | denotes | Data were extracted from electronic medical records. |
| T10 | 865-873 | Sentence | denotes | RESULTS: |
| T11 | 874-938 | Sentence | denotes | 150 patients were included (64.7% male, mean age 64 ± 16 years). |
| T12 | 939-1223 | Sentence | denotes | Visceral fat (VAT) was significantly higher in patients requiring intensive care (p = .032), together with age (p = .009), inflammation markers CRP and LDH (p < .0001, p = .003, respectively), and interstitial pneumonia severity as assessed by a Lung Severity Score (LSS) (p < .0001). |
| T13 | 1224-1400 | Sentence | denotes | Increasing age, lymphocytes, CRP, LDH, D-Dimer, LSS, total abdominal fat as well as VAT were found to have a significant univariate association with the need of intensive care. |
| T14 | 1401-1515 | Sentence | denotes | A multivariate analysis showed that LSS and VAT were independently associated with the need of intensive care (OR: |
| T15 | 1516-1529 | Sentence | denotes | 1.262; 95%CI: |
| T16 | 1530-1560 | Sentence | denotes | 1.0171-1.488; p = .005 and OR: |
| T17 | 1561-1574 | Sentence | denotes | 2.474; 95%CI: |
| T18 | 1575-1612 | Sentence | denotes | 1.017-6.019; p = .046, respectively). |
| T19 | 1613-1695 | Sentence | denotes | CONCLUSIONS: VAT is a marker of worse clinical outcomes in patients with COVID-19. |
| T20 | 1696-1852 | Sentence | denotes | Given the exploratory nature of our study, further investigation is needed to confirm our findings and elucidate the mechanisms underlying such association. |
| T1 | 0-103 | Sentence | denotes | Visceral fat shows the strongest association with the need of intensive Care in Patients with COVID-19. |
| T2 | 104-115 | Sentence | denotes | BACKGROUND: |
| T3 | 116-227 | Sentence | denotes | Obesity was recently identified as a major risk factor for worse COVID-19 severity, especially among the young. |
| T4 | 228-359 | Sentence | denotes | The reason why its impact seems to be less pronounced in the elderly may be due to the concomitant presence of other comorbidities. |
| T5 | 360-431 | Sentence | denotes | However, all reports only focus on BMI, an indirect marker of body fat. |
| T6 | 432-584 | Sentence | denotes | Aim To explore the impact on COVID-19 severity of abdominal fat as a marker of body composition easily collected in patients undergoing a chest CT scan. |
| T7 | 585-593 | Sentence | denotes | METHODS: |
| T8 | 594-811 | Sentence | denotes | Patients included in this retrospective study were consecutively enrolled among those admitted to an Emergency Department in Rome, Italy, who tested positive for SARS-Cov-2 and underwent a chest CT scan in March 2020. |
| T9 | 812-864 | Sentence | denotes | Data were extracted from electronic medical records. |
| T10 | 865-873 | Sentence | denotes | RESULTS: |
| T11 | 874-938 | Sentence | denotes | 150 patients were included (64.7% male, mean age 64 ± 16 years). |
| T12 | 939-1223 | Sentence | denotes | Visceral fat (VAT) was significantly higher in patients requiring intensive care (p = .032), together with age (p = .009), inflammation markers CRP and LDH (p < .0001, p = .003, respectively), and interstitial pneumonia severity as assessed by a Lung Severity Score (LSS) (p < .0001). |
| T13 | 1224-1400 | Sentence | denotes | Increasing age, lymphocytes, CRP, LDH, D-Dimer, LSS, total abdominal fat as well as VAT were found to have a significant univariate association with the need of intensive care. |
| T14 | 1401-1515 | Sentence | denotes | A multivariate analysis showed that LSS and VAT were independently associated with the need of intensive care (OR: |
| T15 | 1516-1529 | Sentence | denotes | 1.262; 95%CI: |
| T16 | 1530-1560 | Sentence | denotes | 1.0171-1.488; p = .005 and OR: |
| T17 | 1561-1574 | Sentence | denotes | 2.474; 95%CI: |
| T18 | 1575-1612 | Sentence | denotes | 1.017-6.019; p = .046, respectively). |
| T19 | 1613-1695 | Sentence | denotes | CONCLUSIONS: VAT is a marker of worse clinical outcomes in patients with COVID-19. |
| T20 | 1696-1852 | Sentence | denotes | Given the exploratory nature of our study, further investigation is needed to confirm our findings and elucidate the mechanisms underlying such association. |